{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:41:12Z","timestamp":1772466072987,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research Project Scheme","award":["PJT-197959"],"award-info":[{"award-number":["PJT-197959"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While cancer risk is elevated in inflammatory bowel disease (IBD), results are less clear for cervical cancer. Screening has made cervical cancer relatively preventable, but geography impacts access, possibly increasing rates of cancer in rural and remote areas. We investigated (1) odds of cervical cancer, (2) cervical cancer screening participation, and (3) impact of geography (eg, rurality) and immunosuppression on the odds of cervical cancer and cervical cancer screening participation in the IBD population in Alberta, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A population-based cohort using administrative healthcare databases (fiscal year 2003\/04-2021\/22) was used to identify females with IBD (n\u2009=\u200922\u2009245), age- and sex-matched 10 to 1 to control subjects (n\u2009=\u2009161\u2009070). The average annual percent change of screening rates and incidence of cervical cancer was calculated through Poisson regression. The odds of cervical cancer were calculated with conditional logistic regression. The role of geography and immunosuppression were assessed in each analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Individuals with IBD had lower odds of cervical cancer (odds ratio, 0.75; 95% confidence interval [CI], 0.68 to 0.83), but immunosuppressed individuals were at greater risk (odds ratio, 1.79; 95% CI, 1.48 to 2.15). Cases and controls had similar screening rates, but immunosuppressed individuals were screened more (incidence rate ratio, 1.05; 95% CI, 1.03 to 1.07). Screening declined among individuals with IBD (average annual percentage change, \u22125.15; 95% CI, \u22125.30 to \u22124.99), but incidence rates of cervical cancer remained stable (average annual percentage change, \u22121.95%; 95% CI, \u22124.25 to 0.41). While urban and metropolitan individuals with IBD were screened more, we observed no geographic variation in risk of cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Similarities in screening between cases and controls suggest that lifestyle factors (eg, human papillomavirus vaccination, sexual history) may underpin the reduced odds of cervical cancer, rather than screening frequency. Efforts should be made to increase screening in immunosuppressed individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf249","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:07:29Z","timestamp":1763701649000},"page":"488-497","source":"Crossref","is-referenced-by-count":0,"title":["Association of Geography With Screening and Development of Cervical Neoplasia in Those With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"32","author":[{"given":"Quinn","family":"Goddard","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta,","place":["Canada"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-7226","authenticated-orcid":false,"given":"Stephanie","family":"Coward","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta,","place":["Canada"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-9054","authenticated-orcid":false,"given":"Cynthia H","family":"Seow","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta,","place":["Canada"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bertazzon","sequence":"additional","affiliation":[{"name":"Department of Geography, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Glaze","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Tom Baker Cancer Center, Department of Oncology, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0556","authenticated-orcid":false,"given":"Gilaad G","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary , Calgary, Alberta,","place":["Canada"]},{"name":"Department of Community Health Sciences, University of Calgary , Calgary, Alberta,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2026030209521144400_izaf249-B1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"2026030209521144400_izaf249-B2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"},{"key":"2026030209521144400_izaf249-B3","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.14309\/ajg.0000000000002687","article-title":"Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis","volume":"119","author":"Coward","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026030209521144400_izaf249-B4","doi-asserted-by":"crossref","first-page":"e00513","DOI":"10.14309\/ctg.0000000000000513","article-title":"Risk of cervical cancer in inflammatory bowel disease: a meta-analysis of population-based studies","volume":"13","author":"Mann","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"2026030209521144400_izaf249-B5","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1111\/jog.14992","article-title":"Association between inflammatory bowel disease and risk of abnormalities of uterine cervix","volume":"47","author":"Cui","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"2026030209521144400_izaf249-B6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00384-014-1892-0","article-title":"Inflammatory bowel disease and risk of cervical cancer: a meta-analysis","volume":"29","author":"Wang","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"2026030209521144400_izaf249-B7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/00365521.2023.2238101","article-title":"Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis","volume":"58","author":"Kim","year":"2023","journal-title":"Scand J Gastroenterol"},{"key":"2026030209521144400_izaf249-B8","author":"Public Health Agency of Canada","year":"2017"},{"key":"2026030209521144400_izaf249-B9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"2026030209521144400_izaf249-B10","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1093\/jcag\/gwad015","article-title":"The 2023 impact of inflammatory bowel disease in Canada: treatment landscape","volume":"6","author":"Murthy","year":"2023","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026030209521144400_izaf249-B11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2147\/CLEP.S178056","article-title":"Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study","volume":"10","author":"Benchimol","year":"2018","journal-title":"Clin Epidemiol"},{"key":"2026030209521144400_izaf249-B12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jcag\/gwac015","article-title":"Inequities in rural and urban health care utilization among individuals diagnosed with inflammatory bowel disease: a retrospective population-based cohort study from Saskatchewan, Canada","volume":"6","author":"Pe\u00f1a-S\u00e1nchez","year":"2023","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026030209521144400_izaf249-B13","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.5888\/pcd16.180447","article-title":"Rural-urban and racial\/ethnic disparities in invasive cervical cancer incidence in the United States, 2010-2014","volume":"16","author":"Yu","year":"2019","journal-title":"Prev Chronic Dis."},{"key":"2026030209521144400_izaf249-B14","doi-asserted-by":"crossref","first-page":"e2417094","DOI":"10.1001\/jamanetworkopen.2024.17094","article-title":"Cervical cancer screening rates among rural and urban females, from 2019 to 2022","volume":"7","author":"Borders","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026030209521144400_izaf249-B15","first-page":"5190","article-title":"Women\u2019s preferences and experiences of cervical cancer screening in rural and remote areas: a systematic review and qualitative meta-synthesis","volume":"19","author":"Majid","year":"2019","journal-title":"Rural Remote Health"},{"key":"2026030209521144400_izaf249-B16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026030209521144400_izaf249-B17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/LGT.0000000000000866","article-title":"Updated review for guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"29","author":"Moscicki","year":"2025","journal-title":"J Low Genit Tract Dis"},{"key":"2026030209521144400_izaf249-B18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/apt.17555","article-title":"Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease","volume":"58","author":"Kreijne","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"2026030209521144400_izaf249-B19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2026030209521144400_izaf249-B20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026030209521144400_izaf249-B21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ecco-jcc\/jjab036","article-title":"Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study","volume":"15","author":"Goetgebuer","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026030209521144400_izaf249-B22","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ibd.20959","article-title":"Lack of association between cervical dysplasia and IBD: a large case-control study","volume":"15","author":"Lees","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2026030209521144400_izaf249-B23","doi-asserted-by":"crossref","first-page":"E711","DOI":"10.1002\/ijc.29209","article-title":"Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study","volume":"136","author":"Dugu\u00e9","year":"2015","journal-title":"Int J Cancer"},{"key":"2026030209521144400_izaf249-B24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cgh.2024.12.011","article-title":"AGA clinical practice update on noncolorectal cancer screening and vaccinations in patients with inflammatory bowel disease: expert review","volume":"23","author":"Caldera","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026030209521144400_izaf249-B25","author":"Government of Alberta","year":"2025"},{"key":"2026030209521144400_izaf249-B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1155\/2012\/278495","article-title":"Development and validation of an administrative case definition for inflammatory bowel diseases","volume":"26","author":"Rezaie","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"2026030209521144400_izaf249-B27","author":"Alberta Health Services","year":"2025"},{"key":"2026030209521144400_izaf249-B28","author":"North American Association of Central Cancer Registries","year":"2018"},{"key":"2026030209521144400_izaf249-B29","author":"Alberta Real World Evidence (RWE) Consortium","year":"2023"},{"key":"2026030209521144400_izaf249-B30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.25259\/CMAS_03_07_2021","article-title":"The Bethesda System for reporting cervical cytology","volume":"19","author":"Pangarkar","year":"2022","journal-title":"Cytojournal"},{"key":"2026030209521144400_izaf249-B31","author":"Government of Alberta","year":"2023"},{"key":"2026030209521144400_izaf249-B32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1503\/cmaj.113-2136","article-title":"Recommendations on screening for cervical cancer","volume":"185","author":"Dickinson","year":"2013","journal-title":"CMAJ"},{"key":"2026030209521144400_izaf249-B33","volume-title":"Cervical Cancer Screening: Clinical Practice Guideline","author":"Toward Optimized Practice (TOP) Cervical Cancer Screening Working Group","year":"2016"},{"key":"2026030209521144400_izaf249-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/LGT.0000000000000574","article-title":"Cervical screening practices and outcomes for young women in response to changed guidelines in Calgary, Canada, 2007-2016","volume":"25","author":"Sayed","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"2026030209521144400_izaf249-B35","author":"Alberta Health Services","year":"2021"},{"key":"2026030209521144400_izaf249-B36","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ibd.21567","article-title":"Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study","volume":"17","author":"Singh","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2026030209521144400_izaf249-B37","author":"Canadian Cancer Society","year":"2025"},{"key":"2026030209521144400_izaf249-B38","author":"Statistics Canada","year":"2022"},{"key":"2026030209521144400_izaf249-B39","author":"The City of Calgary","year":"2025"},{"key":"2026030209521144400_izaf249-B40","author":"City of Edmonton","year":"2019"},{"key":"2026030209521144400_izaf249-B41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2026030209521144400_izaf249-B42","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/ajg.2009.322","article-title":"Adverse events associated with common therapy regimens for moderate-to-severe Crohn\u2019s disease","volume":"104","author":"Marehbian","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2026030209521144400_izaf249-B43","author":"Government of Alberta","year":"2008"},{"key":"2026030209521144400_izaf249-B44","doi-asserted-by":"crossref","first-page":"106071","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","year":"2020","journal-title":"Prev Med"},{"key":"2026030209521144400_izaf249-B45","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/cncr.34213","article-title":"The intersection of sexual orientation with race and ethnicity in cervical cancer screening","volume":"128","author":"Stenzel","year":"2022","journal-title":"Cancer"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf249\/65419639\/izaf249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf249\/65419639\/izaf249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:52:23Z","timestamp":1772463143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/3\/488\/8332379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf249","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,20]]}}}